research
Penn analysis shows low risk of secondary cancers following CAR T cell therapy
Posted in Medicine, Science on 28th Jan, 2024
by Alex Muller
The development of any type of second cancer following CAR T cell therapy is a rare occurrence, as found in an analysis of more than 400 patients treated at Penn Medicine.
Therapeutic peptide developed for triple-negative breast cancer
Posted in Medicine, Science on 27th Jan, 2024
by Alex Muller
Scientists demonstrate how disrupting the Cx26 molecular complex in triple-negative breast cancer cells slowed tumour growth.
Novel Immunotherapy Targets Senescent Cells To Make Chemotherapy More Effective
Posted in Medicine, Science on 27th Jan, 2024
by Alex Muller
New immunotherapy in animal models eliminates senescent cells and improves the effectiveness of chemotherapy.
The potential of PD-L2 inhibitors for cancer treatment
Posted in Medicine, Science on 27th Jan, 2024
by Alex Muller
An international team of scientists have elucidated how cancer cells that have become senescent following chemotherapy activate the PD-L2 protein to protect themselves from the immune system while recruiting immune suppressor cells.
Why Don’t Cancer Immunotherapies Work for Everyone?
Posted in Medicine, Science on 26th Jan, 2024
by Alex Muller
A multi-institutional study co-authored by University of Texas at Arlington scientists uncovered a mechanism by which cancer cells prevent the immune system from activating and attacking the cancerous invaders.